Caribou Biosciences Inc (CRBU)

May 05, 2026

Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference - Investing News Network

May 05, 2026

May 05, 2026

Caribou Biosciences to participate in BofA Securities Health Care event in Las Vegas - Traders Union

May 05, 2026

May 04, 2026

Caribou Biosciences (CRBU) price target decreased by 22.79% to 8.92 - MSN

May 04, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

May 01, 2026

Caribou Biosciences (CRBU) corrects record‑date shares, June 17 virtual annual meeting - Stock Titan

May 01, 2026

Apr 29, 2026

Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - MSN

Apr 29, 2026

Apr 29, 2026

Caribou Biosciences (NASDAQ:CRBU) Stock Price Down 2.3%Here's Why - MarketBeat

Apr 29, 2026

Apr 25, 2026

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - TMX Newsfile

Apr 25, 2026

Apr 24, 2026

Caribou Biosciences (NASDAQ: CRBU) sets 2026 director, auditor and charter votes - Stock Titan

Apr 24, 2026

Apr 24, 2026

CRBU Earnings History & Surprises | EPS & Revenue Results | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill

Apr 24, 2026

Apr 22, 2026

CRBU Caribou Biosciences Inc. posts narrower Q4 2025 loss than consensus forecasts, shares rise 2.33 percent amid upbeat investor sentiment.Product Mix - Xã Thanh Hà

Apr 22, 2026

Apr 22, 2026

Where could Caribou Bio (CRBU) stock be by the end of 2026 (+4.67%) 2026-04-22Stock Screening - Xã Vĩnh Công

Apr 22, 2026

Apr 21, 2026

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - qz.com

Apr 21, 2026

Apr 19, 2026

CRBU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Caribou Biosciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 19, 2026

Apr 19, 2026

CRBU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Caribou Biosciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 19, 2026

Apr 17, 2026

CRBU Forecast, Price Target & Analyst Ratings | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill

Apr 17, 2026

Apr 11, 2026

Investment Recap: Should you avoid Caribou Biosciences Inc stock right now2026 Market WrapUp & AI Based Buy/Sell Signal Reports - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Caribou Biosciences (NASDAQ: CRBU) schedules virtual annual meeting June 17, 2026 - Stock Titan

Apr 10, 2026

Apr 08, 2026

CRBU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 07, 2026

Caribou Biosciences' (CRBU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Apr 07, 2026

Apr 07, 2026

H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Apr 07, 2026

Apr 06, 2026

Earnings Miss: How does Caribou Biosciences Inc compare to its peersWeekly Profit Report & Long-Term Capital Growth Strategies - baoquankhu1.vn

Apr 06, 2026

Apr 03, 2026

CRBU SEC FilingsCaribou Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 03, 2026

Apr 03, 2026

Caribou Biosciences, Inc. (CRBU) stock price, news, quote and history - sg.finance.yahoo.com

Apr 03, 2026

Apr 02, 2026

Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget

Apr 02, 2026

Apr 01, 2026

Caribou Biosciences Granted FDA RMAT Designation for CB-011 Allogeneic Anti-BCMA CAR-T Cell Therapy - Minichart

Apr 01, 2026

Mar 31, 2026

Caribou Biosciences, Inc. Announces the FDA Granted Regenerative Medicine Advanced Therapy Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - marketscreener.com

Mar 31, 2026

Mar 31, 2026

Caribou Biosciences Gains RMAT Status for CB-011 Therapy - TipRanks

Mar 31, 2026

Mar 31, 2026

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - Investing News Network

Mar 31, 2026

Mar 31, 2026

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - Bitget

Mar 31, 2026

Mar 31, 2026

Caribou rises on FDA RMAT designation (CRBU:NASDAQ) - Seeking Alpha

Mar 31, 2026

Mar 31, 2026

Caribou Biosciences Announces The FDA Granted Regenerative Medicine Advanced Therapy (Rmat) Designation To Cb-011 - TradingView

Mar 31, 2026

Mar 31, 2026

Caribou Biosciences receives FDA RMAT designation for CB-011 in multiple myeloma - tradersunion.com

Mar 31, 2026

Mar 31, 2026

FDA grants RMAT designation to Caribou (CRBU) CAR-T CB-011 in multiple myeloma - Stock Titan

Mar 31, 2026

Mar 31, 2026

FDA gives advanced therapy status to Caribou's myeloma CAR-T - Stock Titan

Mar 31, 2026

Mar 26, 2026

Fed Watch: Can Caribou Biosciences Inc expand its profit marginsMarket Activity Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Is Caribou Biosciences Inc a cyclical or defensive stockWeekly Trade Recap & High Conviction Buy Zone Picks - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Caribou Biosciences (NASDAQ:CRBU) Stock Rating Upgraded by Truist Financial - marketbeat.com

Mar 26, 2026

Mar 26, 2026

Hedge Fund Moves: Is Caribou Biosciences Inc stock good for income investors2026 Retail Activity & Daily Market Momentum Tracking - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

How does Caribou Biosciences Inc compare to its peersPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Caribou Biosciences stock faces pressure amid biotech sector volatility and pipeline updates - AD HOC NEWS

Mar 25, 2026

Mar 24, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosc - The National Law Review

Mar 24, 2026

Mar 23, 2026

Caribou Biosciences stock faces pressure amid biotech volatility and pipeline updates - AD HOC NEWS

Mar 23, 2026

Mar 22, 2026

Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - msn.com

Mar 22, 2026